FIELD: biotechnology.
SUBSTANCE: there are presented compositions and methods for preparing a live attenuated influenza vaccine suitable for nasal administration. This vaccine employs a cold-adapted influenza virus which does not contain a virulence factor, containing mutations providing the ability to replicate, sufficient for vaccine production.
EFFECT: vaccines obtained using said method provide significant cross-protection against strains not used for vaccination; said vaccine is safe for children under 2 years old and adults over 49 years old; besides, said cold-adapted virus with a deleted virulence factor can be adapted in order to obtain immunity from causative agents of diseases other than influenza.
9 cl, 12 dwg
Title | Year | Author | Number |
---|---|---|---|
MINUS-CHAIN-CONTAINING ATTENUATED VIRUSES WITH CHANGED ANTAGONISTIC ACTIVITY AS REGARDS FOR INTERFERON FOR APPLYING AS VACCINES AND PHARMACEUTICAL SUBSTANCES | 1999 |
|
RU2236252C2 |
RECOMBINANT INFLUENZA VIRUS STRAIN A/PR8/HK-NS80E85A, EXPRESSING FRAGMENTS OF ESAT-6 AND AG85A MYCOBACTERIUM TUBERCULOSIS ANTIGENS, TO OBTAIN TUBERCULOSIS VECTORED VACCINE | 2018 |
|
RU2678175C1 |
RECOMBINANT INFLUENZA VIRUS A | 2001 |
|
RU2280690C2 |
RECOMBINANT STRAIN OF INFLUENZA VIRUS A/PR8-NS124-TB10_4-2A-HSPX AND METHOD FOR SPECIFIC PREVENTION OF PULMONARY TUBERCULOSIS USING MUCOSAL VACCINE BASED THEREON | 2019 |
|
RU2726106C1 |
ATTENUATED INFLUENZA VECTORS FOR THE PREVENTION AND/OR TREATMENT OF INFECTIOUS DISEASES, AS WELL AS FOR CANCER TREATMENT | 2015 |
|
RU2628690C2 |
RECOMBINANT INFLUENZA VIRUS INTENDED FOR THE PREVENTION OF COVID-19 AND INFLUENZA, METHOD OF ITS PRODUCTION AND USE | 2022 |
|
RU2802058C1 |
METHOD FOR OBTAINING ATTENUATED STRAINS OF INFLUENZA A VIRUS - CANDIDATES FOR LIVE INFLUENZA VACCINES | 2017 |
|
RU2670514C1 |
REASSORTANT A/17/NEW CALEDONIA/99/79(H1N1) INFLUENZA VIRUS STRAIN FOR PRODUCING LIVE INFLUENZA INTRANASAL VACCINE | 2011 |
|
RU2464310C1 |
ATTENUATED GRIPPOSE VECTOR AND MUCOSAL UNIVERSAL GRIPPOSE VACCINE ON ITS BASIS | 2016 |
|
RU2660562C2 |
INFLUENZA VIRUS STRAIN A/Hongkong/1/68/162/35 (H3N2) - UNIVERSAL DONOR OF INTERNAL GENES FOR REASSORTANTS, AND REASSORTANT STRAINS A/SPB/GK/09 (H1N1) AND A/HK/Astana/6:2/2010 (H5N1) PREPARED THEREOF | 2011 |
|
RU2511431C2 |
Authors
Dates
2022-04-22—Published
2017-04-18—Filed